Related Experiment Video
Updated: Dec 6, 2025

17:59
Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice
Published on: April 3, 2011
12.6K
Variable Abnormalities in T and B Cell Subsets in Ataxia Telangiectasia
Tannaz Moeini Shad1,2, Bahman Yousefi1, Parisa Amirifar2,3
1Department of Immunology, Semnan University of Medical Sciences, Semnan, Iran.
Journal of Clinical Immunology
|October 14, 2020
Summary
Ataxia-telangiectasia (AT) patients exhibit broad immune deficiencies, including altered B and T cell populations and impaired T cell proliferation. Understanding these immune defects is crucial for managing infection risk in AT.
Area of Science:
- Immunology
- Genetics
- Clinical Medicine
Background:
- Ataxia-telangiectasia (AT) is a rare genetic disorder caused by ATM gene variants, often presenting with immunological abnormalities.
- This study focuses on characterizing the diverse immunological dysfunctions in AT patients.
Purpose of the Study:
- To investigate immunologic parameters in AT patients, including cell development, activation, proliferation, and class switch recombination (CSR).
- To correlate these immunological findings with the clinical phenotype of AT.
Main Methods:
- Flow cytometry was used to compare peripheral B and T cell subsets in 40 AT patients and 28 healthy controls.
- T cell proliferation response to CD3/CD28 stimulation was assessed in AT patients with and without CSR defects.
Main Results:
- AT patients showed decreased naïve, transitional, and memory B cells, with increased marginal zone-like and CD21low B cells.
- Significant alterations in T cell subsets were observed, including decreased naïve and memory cells and increased effector memory and regulatory T cells.
- Impaired CD4+ T cell proliferation and specific B and T cell defects were noted in patients with CSR defects.
Conclusions:
- AT patients present with a wide range of cellular and humoral immune deficiencies.
- Detailed analysis of T and B cell subsets enhances understanding of AT and associated infection risks.

